-
2025Neural-network model for characterizing stochastic dynamic variability of cellular particles, International Symposium on Biomedical Imaging, 2025..
-
2022Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status., Elife 2022 Jul; 11(): .
-
2022Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry., Nat Commun 2022 Jan; 13(1): 521.
-
2018CCR5 structural plasticity shapes HIV-1 phenotypic properties, PLoS Pathog. 2018 Dec;14(12):e1007432.
-
2018CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis, J. Mol. Biol. 2018 Aug;430(17):2557-2589.
-
2018CCR5 adopts three homodimeric conformations that control cell surface delivery, Sci Signal 2018 05;11(529).
-
2014Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry, J. Biol. Chem. 2014 Jul;289(27):19042-52.
-
2013HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines, Proc. Natl. Acad. Sci. U.S.A. 2013 Jun;110(23):9475-80.
-
2007Identification of a postendocytic sorting sequence in CCR5, Mol. Pharmacol. 2007 Dec;72(6):1497-507.
-
2005On the dimerization of CCR5, Nat. Immunol. 2005 Jun;6(6):535; author reply 535-6.
-
2004Identification of the cytoplasmic domains of CXCR4 involved in Jak2 and STAT3 phosphorylation, J. Biol. Chem. 2005 Feb;280(8):6692-700.
-
2004The composition of the beta-2 adrenergic receptor oligomer affects its membrane trafficking after ligand-induced endocytosis, Mol. Pharmacol. 2005 Jan;67(1):288-97.
-
2001Antigenically distinct conformations of CXCR4, J. Virol. 2001 Oct;75(19):8957-67.
-
2001Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor, J. Virol. 2001 Jun;75(12):5457-64.
-
2001HIV-1 entry and how to block it, AIDS 2001;15 Suppl 5:S3-11.
-
2001Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay, J. Virol. 2001 Jan;75(1):251-9.
-
2000Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities, J. Biol. Chem. 2000 Aug;275(31):23736-44.
-
1999Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses, J. Virol. 1999 Apr;73(4):2576-86.
-
1998The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus, J. Virol. 1998 Aug;72(8):6475-81.
-
1998Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100, J. Virol. 1998 Aug;72(8):6381-8.
-
1998The second extracellular loop of CXCR4 is involved in CD4-independent entry of human immunodeficiency virus type 2, J. Gen. Virol. 1998 Jul;79 ( Pt 7):1793-9.
-
1997HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4, J. Immunol. 1997 Sep;159(6):3000-8.
-
1997Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry, Science 1997 Jun;276(5320):1874-8.
-
1997Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity, J. Virol. 1997 Jun;71(6):4744-51.